Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER).
Matza LS, Boye KS, Stewart KD, Coyne KS, Wullenweber PK, Cutts KN, Jordan JB, Wang Q, Yu M, Currie BM, Malley KG, Ishak KJ, Hietpas RT, García-Pérez LE.
Matza LS, et al.
Diabetes Obes Metab. 2020 Mar;22(3):355-364. doi: 10.1111/dom.13902. Epub 2019 Dec 19.
Diabetes Obes Metab. 2020.
PMID: 31646727
Free PMC article.
Clinical Trial.